3.0
Dec 20, 2024
Current employee
Recommend
CEO approval
Business outlook
Pros
Most departments (except one) and groups are excellent, with helpful and knowledgeable managers and colleagues. Mid-size biotech allows for flexible, interesting and interdisciplinary work. Great senior leadership till mid-2024. Excellent benefits and PTO policy.
Cons
New leadership in R&D in 2024 significantly impacted company culture and encourages obsequious behavior. Located in CT so not as many other biotech/pharma opportunities in the area.